SmallCaps
ASX:OCCPharmaceuticals, Biotechnology & Life SciencesBiotechnology

Orthocell Ltd

Orthocell Limited is an Australia-based regenerative medicine company.

$0.710 ⁠$0.010 (1.39%)AUD · Closed
-36.2%52-week return
Day Range
$0.695$0.710
52 Week Range
$0.695$1.600
Volume
240.98K
Avg Volume (10D)
268.68K
Market Cap
$193.40M
The company

The business

What Orthocell Ltd does

Orthocell Limited is an Australia-based regenerative medicine company. The Company is focused on regenerating mobility for patients by developing products for the repair of a variety of bone and soft tissue injuries. Its portfolio of products includes Striate+, Remplir, and OrthoACI. Striate+ is an acellular resorbable collagen membrane used for guided bone and tissue regeneration in dental applications. Remplir is a collagen-based nerve wrap designed to support nerve repair surgery in peripheral nerve repair. OrthoACI, or Autologous Chondrocyte Implantation, offers treatment for symptomatic defects of the articulating cartilage of the joints. OrthoACI uses the patient’s own healthy cartilage cells called chondrocytes to assist the regeneration of damaged cartilage. The Company is engaged in the development of its tendon cell therapy in the United States. Its autologous tendon therapy is an advanced injectable cellular therapy for the treatment of chronic tendon injuries.

Incorporated
AUS
Public since
2014-08-12
Shareholders
8,653
Advertisement

Small Caps Research

Independent ASX small-cap coverage

No research on Orthocell Ltd yet

We cover the ASX small-cap market one company at a time. Request coverage and we’ll prioritise OCC based on demand.

Share price & key data

Share price

OHLC · volume · moving averages
$0.710-$0.075 (-9.55%)over 6M
Hi$1.110Lo$0.695
Price-sensitive newsVolumePrev close · 52W range

Market Statistics

Today
Open
$0.705
Prev Close
$0.720
Day High
$0.710
Day Low
$0.695
52wk High
$1.600
52wk Low
$0.695

Valuation

Multiples
Market Cap
$193.40M
Shares Out
272.39M
Price/Book
4.88

Trading Activity

Volume & book
Volume
240.98K
Value Traded
$169.81K
Bid
$0.695 × 1,000
Ask
$0.720 × 45,000
Avg Vol 10D
268.68K

Performance

Total return
1 Day
-3.27%
5 Day
-4.52%
13 Week
-1.33%
52 Week
-36.21%
YTD
-31.80%
Peers & news

Looking for charts & signals? See the tab.

◆ FREE MEMBER ACCESS

Unlock the full research library - free.

Create a free account to access every broker report, CEO interview, IPO alert, and daily market wrap. No credit card. No paywall.

Full broker research library
Complete CEO interview archive
IPO calendar and alerts
New research alerts
Mobile notifications
Members-only market wraps
◆ Free account
Start free
No credit card · Takes 30 seconds · 200,000+ members
Unlock free access →
Continue with Google or email through our secure Auth0 signup.